nodes	percent_of_prediction	percent_of_DWPC	metapath
Lithium—IMPA1—blood—hepatitis B	0.0265	0.16	CbGeAlD
Lithium—IMPA1—liver—hepatitis B	0.0207	0.125	CbGeAlD
Lithium—IMPA2—blood—hepatitis B	0.0199	0.12	CbGeAlD
Lithium—GSK3B—blood—hepatitis B	0.0195	0.118	CbGeAlD
Lithium—GRIA3—liver—hepatitis B	0.0176	0.107	CbGeAlD
Lithium—GSK3A—blood—hepatitis B	0.017	0.103	CbGeAlD
Lithium—IMPA2—liver—hepatitis B	0.0156	0.0941	CbGeAlD
Lithium—GSK3B—liver—hepatitis B	0.0153	0.0923	CbGeAlD
Lithium—Glycosuria—Entecavir—hepatitis B	0.0133	0.047	CcSEcCtD
Lithium—GSK3A—liver—hepatitis B	0.0133	0.0803	CbGeAlD
Lithium—Glycosuria—Adefovir Dipivoxil—hepatitis B	0.013	0.0458	CcSEcCtD
Lithium—Chest discomfort—Telbivudine—hepatitis B	0.01	0.0353	CcSEcCtD
Lithium—Folliculitis—Lamivudine—hepatitis B	0.00793	0.028	CcSEcCtD
Lithium—Hyperglycaemia—Entecavir—hepatitis B	0.00609	0.0215	CcSEcCtD
Lithium—Weight decreased—Adefovir Dipivoxil—hepatitis B	0.00596	0.0211	CcSEcCtD
Lithium—Gastritis—Telbivudine—hepatitis B	0.00568	0.0201	CcSEcCtD
Lithium—Muscular weakness—Telbivudine—hepatitis B	0.00566	0.02	CcSEcCtD
Lithium—Muscle twitching—Lamivudine—hepatitis B	0.00508	0.0179	CcSEcCtD
Lithium—Alopecia—Entecavir—hepatitis B	0.00478	0.0169	CcSEcCtD
Lithium—Flatulence—Adefovir Dipivoxil—hepatitis B	0.00453	0.016	CcSEcCtD
Lithium—Urine output increased—Lamivudine—hepatitis B	0.00451	0.0159	CcSEcCtD
Lithium—Polyuria—Lamivudine—hepatitis B	0.00412	0.0146	CcSEcCtD
Lithium—Thirst—Lamivudine—hepatitis B	0.0038	0.0134	CcSEcCtD
Lithium—Dysgeusia—Telbivudine—hepatitis B	0.00379	0.0134	CcSEcCtD
Lithium—Anorexia—Adefovir Dipivoxil—hepatitis B	0.00357	0.0126	CcSEcCtD
Lithium—Somnolence—Entecavir—hepatitis B	0.00342	0.0121	CcSEcCtD
Lithium—Musculoskeletal discomfort—Adefovir Dipivoxil—hepatitis B	0.00342	0.0121	CcSEcCtD
Lithium—Dyspepsia—Entecavir—hepatitis B	0.00338	0.012	CcSEcCtD
Lithium—Dehydration—Lamivudine—hepatitis B	0.00337	0.0119	CcSEcCtD
Lithium—Fatigue—Entecavir—hepatitis B	0.00331	0.0117	CcSEcCtD
Lithium—Dyspepsia—Adefovir Dipivoxil—hepatitis B	0.0033	0.0117	CcSEcCtD
Lithium—Arthralgia—Telbivudine—hepatitis B	0.00329	0.0116	CcSEcCtD
Lithium—Decreased appetite—Adefovir Dipivoxil—hepatitis B	0.00326	0.0115	CcSEcCtD
Lithium—Discomfort—Telbivudine—hepatitis B	0.00325	0.0115	CcSEcCtD
Lithium—Muscular weakness—Lamivudine—hepatitis B	0.00319	0.0113	CcSEcCtD
Lithium—Gastrointestinal pain—Entecavir—hepatitis B	0.00314	0.0111	CcSEcCtD
Lithium—Gastrointestinal pain—Adefovir Dipivoxil—hepatitis B	0.00307	0.0108	CcSEcCtD
Lithium—Abdominal pain—Entecavir—hepatitis B	0.00304	0.0107	CcSEcCtD
Lithium—Body temperature increased—Entecavir—hepatitis B	0.00304	0.0107	CcSEcCtD
Lithium—Abdominal pain—Adefovir Dipivoxil—hepatitis B	0.00296	0.0105	CcSEcCtD
Lithium—Body temperature increased—Adefovir Dipivoxil—hepatitis B	0.00296	0.0105	CcSEcCtD
Lithium—Musculoskeletal discomfort—Telbivudine—hepatitis B	0.00288	0.0102	CcSEcCtD
Lithium—Hyperglycaemia—Lamivudine—hepatitis B	0.00282	0.00997	CcSEcCtD
Lithium—Dyspepsia—Telbivudine—hepatitis B	0.00278	0.00982	CcSEcCtD
Lithium—Asthenia—Entecavir—hepatitis B	0.00276	0.00974	CcSEcCtD
Lithium—Fatigue—Telbivudine—hepatitis B	0.00272	0.00962	CcSEcCtD
Lithium—Asthenia—Adefovir Dipivoxil—hepatitis B	0.00269	0.00951	CcSEcCtD
Lithium—Diarrhoea—Entecavir—hepatitis B	0.00263	0.00929	CcSEcCtD
Lithium—Feeling abnormal—Telbivudine—hepatitis B	0.0026	0.00919	CcSEcCtD
Lithium—Gastrointestinal pain—Telbivudine—hepatitis B	0.00258	0.00912	CcSEcCtD
Lithium—Diarrhoea—Adefovir Dipivoxil—hepatitis B	0.00256	0.00906	CcSEcCtD
Lithium—Dizziness—Entecavir—hepatitis B	0.00254	0.00898	CcSEcCtD
Lithium—Abdominal pain—Telbivudine—hepatitis B	0.00249	0.00882	CcSEcCtD
Lithium—Body temperature increased—Telbivudine—hepatitis B	0.00249	0.00882	CcSEcCtD
Lithium—Vomiting—Entecavir—hepatitis B	0.00244	0.00863	CcSEcCtD
Lithium—Rash—Entecavir—hepatitis B	0.00242	0.00856	CcSEcCtD
Lithium—Dermatitis—Entecavir—hepatitis B	0.00242	0.00855	CcSEcCtD
Lithium—Headache—Entecavir—hepatitis B	0.00241	0.00851	CcSEcCtD
Lithium—Vomiting—Adefovir Dipivoxil—hepatitis B	0.00238	0.00842	CcSEcCtD
Lithium—Rash—Adefovir Dipivoxil—hepatitis B	0.00236	0.00835	CcSEcCtD
Lithium—Dermatitis—Adefovir Dipivoxil—hepatitis B	0.00236	0.00835	CcSEcCtD
Lithium—Headache—Adefovir Dipivoxil—hepatitis B	0.00235	0.0083	CcSEcCtD
Lithium—Nausea—Entecavir—hepatitis B	0.00228	0.00807	CcSEcCtD
Lithium—Asthenia—Telbivudine—hepatitis B	0.00226	0.008	CcSEcCtD
Lithium—Nausea—Adefovir Dipivoxil—hepatitis B	0.00223	0.00787	CcSEcCtD
Lithium—Alopecia—Lamivudine—hepatitis B	0.00221	0.00782	CcSEcCtD
Lithium—Diarrhoea—Telbivudine—hepatitis B	0.00216	0.00763	CcSEcCtD
Lithium—Flatulence—Lamivudine—hepatitis B	0.00215	0.00759	CcSEcCtD
Lithium—Dysgeusia—Lamivudine—hepatitis B	0.00213	0.00754	CcSEcCtD
Lithium—Dizziness—Telbivudine—hepatitis B	0.00209	0.00738	CcSEcCtD
Lithium—Tremor—Lamivudine—hepatitis B	0.00204	0.00722	CcSEcCtD
Lithium—Vomiting—Telbivudine—hepatitis B	0.00201	0.00709	CcSEcCtD
Lithium—Angioedema—Lamivudine—hepatitis B	0.00199	0.00704	CcSEcCtD
Lithium—Rash—Telbivudine—hepatitis B	0.00199	0.00703	CcSEcCtD
Lithium—Dermatitis—Telbivudine—hepatitis B	0.00199	0.00703	CcSEcCtD
Lithium—Headache—Telbivudine—hepatitis B	0.00198	0.00699	CcSEcCtD
Lithium—Vertigo—Lamivudine—hepatitis B	0.00196	0.00692	CcSEcCtD
Lithium—Syncope—Lamivudine—hepatitis B	0.00195	0.00691	CcSEcCtD
Lithium—Loss of consciousness—Lamivudine—hepatitis B	0.00192	0.00677	CcSEcCtD
Lithium—Convulsion—Lamivudine—hepatitis B	0.00189	0.00667	CcSEcCtD
Lithium—Nausea—Telbivudine—hepatitis B	0.00187	0.00663	CcSEcCtD
Lithium—Arthralgia—Lamivudine—hepatitis B	0.00186	0.00656	CcSEcCtD
Lithium—Discomfort—Lamivudine—hepatitis B	0.00183	0.00648	CcSEcCtD
Lithium—Dry mouth—Lamivudine—hepatitis B	0.00181	0.00641	CcSEcCtD
Lithium—Confusional state—Lamivudine—hepatitis B	0.00179	0.00634	CcSEcCtD
Lithium—Oedema—Lamivudine—hepatitis B	0.00178	0.00629	CcSEcCtD
Lithium—Shock—Lamivudine—hepatitis B	0.00175	0.00618	CcSEcCtD
Lithium—Anorexia—Lamivudine—hepatitis B	0.0017	0.00599	CcSEcCtD
Lithium—Hypotension—Lamivudine—hepatitis B	0.00166	0.00587	CcSEcCtD
Lithium—Musculoskeletal discomfort—Lamivudine—hepatitis B	0.00162	0.00573	CcSEcCtD
Lithium—Somnolence—Lamivudine—hepatitis B	0.00158	0.00559	CcSEcCtD
Lithium—Dyspepsia—Lamivudine—hepatitis B	0.00157	0.00553	CcSEcCtD
Lithium—Decreased appetite—Lamivudine—hepatitis B	0.00155	0.00546	CcSEcCtD
Lithium—Fatigue—Lamivudine—hepatitis B	0.00153	0.00542	CcSEcCtD
Lithium—Feeling abnormal—Lamivudine—hepatitis B	0.00147	0.00518	CcSEcCtD
Lithium—Gastrointestinal pain—Lamivudine—hepatitis B	0.00145	0.00514	CcSEcCtD
Lithium—Body temperature increased—Lamivudine—hepatitis B	0.00141	0.00497	CcSEcCtD
Lithium—Abdominal pain—Lamivudine—hepatitis B	0.00141	0.00497	CcSEcCtD
Lithium—Asthenia—Lamivudine—hepatitis B	0.00128	0.00451	CcSEcCtD
Lithium—Diarrhoea—Lamivudine—hepatitis B	0.00122	0.0043	CcSEcCtD
Lithium—Dizziness—Lamivudine—hepatitis B	0.00118	0.00416	CcSEcCtD
Lithium—Vomiting—Lamivudine—hepatitis B	0.00113	0.004	CcSEcCtD
Lithium—Rash—Lamivudine—hepatitis B	0.00112	0.00396	CcSEcCtD
Lithium—Dermatitis—Lamivudine—hepatitis B	0.00112	0.00396	CcSEcCtD
Lithium—Headache—Lamivudine—hepatitis B	0.00111	0.00394	CcSEcCtD
Lithium—Nausea—Lamivudine—hepatitis B	0.00106	0.00373	CcSEcCtD
Lithium—GSK3A—Innate Immune System—CD14—hepatitis B	0.000808	0.00146	CbGpPWpGaD
Lithium—GSK3A—Innate Immune System—IFNA2—hepatitis B	0.000808	0.00146	CbGpPWpGaD
Lithium—GSK3B—Disease—APOBEC3G—hepatitis B	0.000807	0.00146	CbGpPWpGaD
Lithium—GSK3B—Disease—SAG—hepatitis B	0.000807	0.00146	CbGpPWpGaD
Lithium—GSK3A—B Cell Activation—CDKN1A—hepatitis B	0.000807	0.00146	CbGpPWpGaD
Lithium—GSK3A—B Cell Activation—PTEN—hepatitis B	0.000805	0.00146	CbGpPWpGaD
Lithium—GSK3A—B Cell Activation—NFKB1—hepatitis B	0.000801	0.00145	CbGpPWpGaD
Lithium—GSK3B—DNA Damage Response (only ATM dependent)—TGFB1—hepatitis B	0.000785	0.00142	CbGpPWpGaD
Lithium—GSK3B—BDNF signaling pathway—CTNNB1—hepatitis B	0.000778	0.00141	CbGpPWpGaD
Lithium—GSK3B—Signaling by SCF-KIT—CDKN1A—hepatitis B	0.000772	0.0014	CbGpPWpGaD
Lithium—GSK3A—NGF signalling via TRKA from the plasma membrane—CDKN1A—hepatitis B	0.000772	0.0014	CbGpPWpGaD
Lithium—GSK3B—Signaling by SCF-KIT—PTEN—hepatitis B	0.000771	0.0014	CbGpPWpGaD
Lithium—GSK3A—NGF signalling via TRKA from the plasma membrane—PTEN—hepatitis B	0.00077	0.0014	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—RIT2—hepatitis B	0.000764	0.00139	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—SAG—hepatitis B	0.000764	0.00139	CbGpPWpGaD
Lithium—GSK3B—Immune System—PDCD1—hepatitis B	0.000758	0.00137	CbGpPWpGaD
Lithium—GSK3B—BDNF signaling pathway—NFKB1—hepatitis B	0.000754	0.00137	CbGpPWpGaD
Lithium—GSK3B—Glucocorticoid receptor regulatory network—IL6—hepatitis B	0.000743	0.00135	CbGpPWpGaD
Lithium—GSK3B—Downstream signaling of activated FGFR—CDKN1A—hepatitis B	0.000739	0.00134	CbGpPWpGaD
Lithium—GSK3B—Downstream signaling of activated FGFR—PTEN—hepatitis B	0.000737	0.00134	CbGpPWpGaD
Lithium—GSK3B—Signaling by ERBB4—CDKN1A—hepatitis B	0.000727	0.00132	CbGpPWpGaD
Lithium—GSK3B—Signaling by ERBB4—PTEN—hepatitis B	0.000726	0.00132	CbGpPWpGaD
Lithium—GSK3B—Immune System—IFNGR1—hepatitis B	0.000704	0.00128	CbGpPWpGaD
Lithium—GSK3B—Adaptive Immune System—HSPA5—hepatitis B	0.0007	0.00127	CbGpPWpGaD
Lithium—GSK3B—Insulin Signaling—PTEN—hepatitis B	0.000697	0.00126	CbGpPWpGaD
Lithium—GSK3B—Downstream signal transduction—CDKN1A—hepatitis B	0.000695	0.00126	CbGpPWpGaD
Lithium—GSK3B—Downstream signal transduction—PTEN—hepatitis B	0.000693	0.00126	CbGpPWpGaD
Lithium—GSK3B—Signaling by FGFR—CDKN1A—hepatitis B	0.000691	0.00125	CbGpPWpGaD
Lithium—GSK3B—Signaling by FGFR—PTEN—hepatitis B	0.00069	0.00125	CbGpPWpGaD
Lithium—GSK3B—Signaling by ERBB2—CDKN1A—hepatitis B	0.000688	0.00125	CbGpPWpGaD
Lithium—GSK3B—Signaling by ERBB2—PTEN—hepatitis B	0.000686	0.00124	CbGpPWpGaD
Lithium—GSK3B—DAP12 signaling—CDKN1A—hepatitis B	0.000684	0.00124	CbGpPWpGaD
Lithium—GSK3B—DAP12 signaling—PTEN—hepatitis B	0.000683	0.00124	CbGpPWpGaD
Lithium—GSK3B—Cell Cycle—TP53—hepatitis B	0.000682	0.00124	CbGpPWpGaD
Lithium—GSK3B—Wnt Signaling Pathway and Pluripotency—TP53—hepatitis B	0.000682	0.00124	CbGpPWpGaD
Lithium—GSK3A—Integrated Pancreatic Cancer Pathway—TGFB1—hepatitis B	0.000678	0.00123	CbGpPWpGaD
Lithium—GSK3B—Downstream signaling events of B Cell Receptor (BCR)—CDKN1A—hepatitis B	0.000675	0.00122	CbGpPWpGaD
Lithium—GSK3A—Integrated Breast Cancer Pathway—TP53—hepatitis B	0.000674	0.00122	CbGpPWpGaD
Lithium—GSK3B—Downstream signaling events of B Cell Receptor (BCR)—PTEN—hepatitis B	0.000673	0.00122	CbGpPWpGaD
Lithium—GSK3B—Downstream signaling events of B Cell Receptor (BCR)—NFKB1—hepatitis B	0.00067	0.00121	CbGpPWpGaD
Lithium—GSK3B—Senescence and Autophagy in Cancer—TP53—hepatitis B	0.000666	0.00121	CbGpPWpGaD
Lithium—GSK3B—Innate Immune System—TLR2—hepatitis B	0.000662	0.0012	CbGpPWpGaD
Lithium—GSK3B—Adaptive Immune System—HLA-DPB1—hepatitis B	0.000661	0.0012	CbGpPWpGaD
Lithium—GSK3A—Adaptive Immune System—CD40LG—hepatitis B	0.00066	0.0012	CbGpPWpGaD
Lithium—GSK3B—Innate Immune System—IFNB1—hepatitis B	0.000658	0.00119	CbGpPWpGaD
Lithium—GSK3A—Adaptive Immune System—CD8A—hepatitis B	0.000652	0.00118	CbGpPWpGaD
Lithium—GSK3A—Signaling by SCF-KIT—IL6—hepatitis B	0.000652	0.00118	CbGpPWpGaD
Lithium—GSK3B—DNA Damage Response (only ATM dependent)—TP53—hepatitis B	0.000646	0.00117	CbGpPWpGaD
Lithium—GSK3B—DAP12 interactions—CDKN1A—hepatitis B	0.000644	0.00117	CbGpPWpGaD
Lithium—GSK3B—Signaling by FGFR in disease—CDKN1A—hepatitis B	0.000644	0.00117	CbGpPWpGaD
Lithium—GSK3B—Fc epsilon receptor (FCERI) signaling—CDKN1A—hepatitis B	0.000644	0.00117	CbGpPWpGaD
Lithium—GSK3B—Signaling by FGFR in disease—PTEN—hepatitis B	0.000643	0.00116	CbGpPWpGaD
Lithium—GSK3B—DAP12 interactions—PTEN—hepatitis B	0.000643	0.00116	CbGpPWpGaD
Lithium—GSK3B—Fc epsilon receptor (FCERI) signaling—PTEN—hepatitis B	0.000643	0.00116	CbGpPWpGaD
Lithium—GSK3B—Innate Immune System—IFNA1—hepatitis B	0.000642	0.00116	CbGpPWpGaD
Lithium—GSK3B—Fc epsilon receptor (FCERI) signaling—NFKB1—hepatitis B	0.000639	0.00116	CbGpPWpGaD
Lithium—GSK3B—Signaling by EGFR—CDKN1A—hepatitis B	0.000638	0.00116	CbGpPWpGaD
Lithium—GSK3B—Signaling by EGFR—PTEN—hepatitis B	0.000637	0.00115	CbGpPWpGaD
Lithium—GSK3A—Integrated Pancreatic Cancer Pathway—TNF—hepatitis B	0.000633	0.00115	CbGpPWpGaD
Lithium—GSK3B—Signaling by EGFR in Cancer—CDKN1A—hepatitis B	0.000633	0.00115	CbGpPWpGaD
Lithium—GSK3B—Signaling by EGFR in Cancer—PTEN—hepatitis B	0.000631	0.00114	CbGpPWpGaD
Lithium—GSK3B—Signaling by PDGF—CDKN1A—hepatitis B	0.00063	0.00114	CbGpPWpGaD
Lithium—GSK3B—Signaling by PDGF—PTEN—hepatitis B	0.000628	0.00114	CbGpPWpGaD
Lithium—GSK3A—Downstream signaling of activated FGFR—IL6—hepatitis B	0.000623	0.00113	CbGpPWpGaD
Lithium—GSK3B—Focal Adhesion—CTNNB1—hepatitis B	0.000623	0.00113	CbGpPWpGaD
Lithium—GSK3A—Signaling by ERBB4—IL6—hepatitis B	0.000614	0.00111	CbGpPWpGaD
Lithium—GSK3B—Senescence and Autophagy in Cancer—IL6—hepatitis B	0.00061	0.0011	CbGpPWpGaD
Lithium—GSK3B—Focal Adhesion—PTEN—hepatitis B	0.000607	0.0011	CbGpPWpGaD
Lithium—GSK3B—Immune System—MX1—hepatitis B	0.000606	0.0011	CbGpPWpGaD
Lithium—GSK3B—Innate Immune System—CD14—hepatitis B	0.000597	0.00108	CbGpPWpGaD
Lithium—GSK3B—Innate Immune System—IFNA2—hepatitis B	0.000597	0.00108	CbGpPWpGaD
Lithium—GSK3B—B Cell Activation—CDKN1A—hepatitis B	0.000596	0.00108	CbGpPWpGaD
Lithium—GSK3B—B Cell Activation—PTEN—hepatitis B	0.000595	0.00108	CbGpPWpGaD
Lithium—IMPA2—Metabolism—ALB—hepatitis B	0.000594	0.00108	CbGpPWpGaD
Lithium—GSK3A—Signaling by NGF—CDKN1A—hepatitis B	0.000594	0.00108	CbGpPWpGaD
Lithium—GSK3A—Signaling by NGF—PTEN—hepatitis B	0.000592	0.00107	CbGpPWpGaD
Lithium—GSK3B—B Cell Activation—NFKB1—hepatitis B	0.000592	0.00107	CbGpPWpGaD
Lithium—GSK3A—Signaling by NGF—NFKB1—hepatitis B	0.000589	0.00107	CbGpPWpGaD
Lithium—GSK3A—Downstream signal transduction—IL6—hepatitis B	0.000586	0.00106	CbGpPWpGaD
Lithium—GSK3A—Signaling by FGFR—IL6—hepatitis B	0.000583	0.00106	CbGpPWpGaD
Lithium—GSK3A—Adaptive Immune System—HLA-A—hepatitis B	0.000582	0.00105	CbGpPWpGaD
Lithium—GSK3B—Circadian rythm related genes—PTEN—hepatitis B	0.00058	0.00105	CbGpPWpGaD
Lithium—GSK3A—Signaling by ERBB2—IL6—hepatitis B	0.00058	0.00105	CbGpPWpGaD
Lithium—GSK3A—DAP12 signaling—IL6—hepatitis B	0.000577	0.00105	CbGpPWpGaD
Lithium—GSK3A—Immune System—HSPA5—hepatitis B	0.000575	0.00104	CbGpPWpGaD
Lithium—GSK3B—Cellular responses to stress—CDKN2A—hepatitis B	0.000572	0.00104	CbGpPWpGaD
Lithium—GSK3B—NGF signalling via TRKA from the plasma membrane—CDKN1A—hepatitis B	0.00057	0.00103	CbGpPWpGaD
Lithium—GSK3B—NGF signalling via TRKA from the plasma membrane—PTEN—hepatitis B	0.000569	0.00103	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—SAG—hepatitis B	0.000565	0.00102	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—RIT2—hepatitis B	0.000565	0.00102	CbGpPWpGaD
Lithium—GSK3A—Integrated Pancreatic Cancer Pathway—TP53—hepatitis B	0.000558	0.00101	CbGpPWpGaD
Lithium—GSK3B—TCF dependent signaling in response to WNT—CTNNB1—hepatitis B	0.000558	0.00101	CbGpPWpGaD
Lithium—GSK3A—Innate Immune System—TLR4—hepatitis B	0.000554	0.001	CbGpPWpGaD
Lithium—GSK3A—Fc epsilon receptor (FCERI) signaling—IL6—hepatitis B	0.000543	0.000984	CbGpPWpGaD
Lithium—GSK3A—Signaling by FGFR in disease—IL6—hepatitis B	0.000543	0.000984	CbGpPWpGaD
Lithium—GSK3A—DAP12 interactions—IL6—hepatitis B	0.000543	0.000984	CbGpPWpGaD
Lithium—GSK3A—Immune System—HLA-DPB1—hepatitis B	0.000543	0.000984	CbGpPWpGaD
Lithium—GSK3B—RNF mutants show enhanced WNT signaling and proliferation—CTNNB1—hepatitis B	0.00054	0.000979	CbGpPWpGaD
Lithium—GSK3A—Signaling by EGFR—IL6—hepatitis B	0.000538	0.000976	CbGpPWpGaD
Lithium—GSK3A—Signaling by EGFR in Cancer—IL6—hepatitis B	0.000534	0.000967	CbGpPWpGaD
Lithium—GSK3A—Adaptive Immune System—HLA-DRB1—hepatitis B	0.000531	0.000963	CbGpPWpGaD
Lithium—GSK3A—Signaling by PDGF—IL6—hepatitis B	0.000531	0.000963	CbGpPWpGaD
Lithium—IMPA1—Metabolism—ALB—hepatitis B	0.00053	0.00096	CbGpPWpGaD
Lithium—GSK3A—Immune System—TLR2—hepatitis B	0.000522	0.000946	CbGpPWpGaD
Lithium—GSK3A—Disease—GOT2—hepatitis B	0.000519	0.00094	CbGpPWpGaD
Lithium—GSK3A—Immune System—IFNB1—hepatitis B	0.000518	0.000939	CbGpPWpGaD
Lithium—GSK3A—Immune System—IFNA1—hepatitis B	0.000506	0.000917	CbGpPWpGaD
Lithium—GSK3B—Signaling by WNT in cancer—CTNNB1—hepatitis B	0.000502	0.000909	CbGpPWpGaD
Lithium—GSK3B—Adaptive Immune System—CD40LG—hepatitis B	0.000488	0.000884	CbGpPWpGaD
Lithium—GSK3B—Adaptive Immune System—CD8A—hepatitis B	0.000482	0.000874	CbGpPWpGaD
Lithium—GSK3B—Signaling by SCF-KIT—IL6—hepatitis B	0.000481	0.000873	CbGpPWpGaD
Lithium—GSK3A—NGF signalling via TRKA from the plasma membrane—IL6—hepatitis B	0.000481	0.000872	CbGpPWpGaD
Lithium—GSK3A—Immune System—CD14—hepatitis B	0.000471	0.000853	CbGpPWpGaD
Lithium—GSK3A—Immune System—IFNA2—hepatitis B	0.000471	0.000853	CbGpPWpGaD
Lithium—GSK3B—Cellular responses to stress—CDKN1A—hepatitis B	0.000468	0.000848	CbGpPWpGaD
Lithium—GSK3A—Metabolism of proteins—F2—hepatitis B	0.000466	0.000844	CbGpPWpGaD
Lithium—GSK3B—Cellular responses to stress—NFKB1—hepatitis B	0.000464	0.000842	CbGpPWpGaD
Lithium—GSK3B—Downstream signaling of activated FGFR—IL6—hepatitis B	0.000461	0.000835	CbGpPWpGaD
Lithium—IMPA2—Metabolism—PTEN—hepatitis B	0.000453	0.000822	CbGpPWpGaD
Lithium—GSK3B—Signaling by ERBB4—IL6—hepatitis B	0.000453	0.000822	CbGpPWpGaD
Lithium—GSK3A—Disease—GOT1—hepatitis B	0.000448	0.000811	CbGpPWpGaD
Lithium—GSK3B—Signaling by NGF—CDKN1A—hepatitis B	0.000439	0.000795	CbGpPWpGaD
Lithium—GSK3B—Signaling by NGF—PTEN—hepatitis B	0.000438	0.000793	CbGpPWpGaD
Lithium—GSK3B—Signaling by NGF—NFKB1—hepatitis B	0.000436	0.000789	CbGpPWpGaD
Lithium—GSK3B—Downstream signal transduction—IL6—hepatitis B	0.000433	0.000785	CbGpPWpGaD
Lithium—GSK3B—Signaling by FGFR—IL6—hepatitis B	0.000431	0.000781	CbGpPWpGaD
Lithium—GSK3B—Adaptive Immune System—HLA-A—hepatitis B	0.00043	0.000779	CbGpPWpGaD
Lithium—GSK3B—Signaling by ERBB2—IL6—hepatitis B	0.000429	0.000777	CbGpPWpGaD
Lithium—GSK3B—DAP12 signaling—IL6—hepatitis B	0.000427	0.000773	CbGpPWpGaD
Lithium—GSK3B—Immune System—HSPA5—hepatitis B	0.000425	0.00077	CbGpPWpGaD
Lithium—GSK3B—Signaling by Wnt—CTNNB1—hepatitis B	0.000414	0.00075	CbGpPWpGaD
Lithium—GSK3B—Innate Immune System—TLR4—hepatitis B	0.000409	0.000742	CbGpPWpGaD
Lithium—IMPA1—Metabolism—PTEN—hepatitis B	0.000404	0.000732	CbGpPWpGaD
Lithium—GSK3A—Immune System—IL18—hepatitis B	0.000402	0.000728	CbGpPWpGaD
Lithium—GSK3B—DAP12 interactions—IL6—hepatitis B	0.000401	0.000727	CbGpPWpGaD
Lithium—GSK3B—Fc epsilon receptor (FCERI) signaling—IL6—hepatitis B	0.000401	0.000727	CbGpPWpGaD
Lithium—GSK3B—Signaling by FGFR in disease—IL6—hepatitis B	0.000401	0.000727	CbGpPWpGaD
Lithium—GSK3B—Immune System—HLA-DPB1—hepatitis B	0.000401	0.000727	CbGpPWpGaD
Lithium—GSK3A—Immune System—CD40LG—hepatitis B	0.0004	0.000725	CbGpPWpGaD
Lithium—GSK3B—Signaling by EGFR—IL6—hepatitis B	0.000398	0.000721	CbGpPWpGaD
Lithium—GSK3B—Circadian rythm related genes—TP53—hepatitis B	0.000396	0.000718	CbGpPWpGaD
Lithium—GSK3A—Immune System—CD8A—hepatitis B	0.000396	0.000717	CbGpPWpGaD
Lithium—GSK3B—Signaling by EGFR in Cancer—IL6—hepatitis B	0.000394	0.000715	CbGpPWpGaD
Lithium—GSK3B—Adaptive Immune System—HLA-DRB1—hepatitis B	0.000393	0.000711	CbGpPWpGaD
Lithium—GSK3B—Signaling by PDGF—IL6—hepatitis B	0.000393	0.000711	CbGpPWpGaD
Lithium—GSK3A—Innate Immune System—CD4—hepatitis B	0.00039	0.000707	CbGpPWpGaD
Lithium—GSK3B—Immune System—TLR2—hepatitis B	0.000386	0.000699	CbGpPWpGaD
Lithium—GSK3B—Disease—GOT2—hepatitis B	0.000383	0.000694	CbGpPWpGaD
Lithium—GSK3B—Immune System—IFNB1—hepatitis B	0.000383	0.000694	CbGpPWpGaD
Lithium—GSK3A—Adaptive Immune System—CD4—hepatitis B	0.000375	0.000679	CbGpPWpGaD
Lithium—GSK3B—Immune System—IFNA1—hepatitis B	0.000374	0.000677	CbGpPWpGaD
Lithium—GSK3A—Signaling by NGF—IL6—hepatitis B	0.00037	0.000671	CbGpPWpGaD
Lithium—GSK3B—Circadian rythm related genes—IL6—hepatitis B	0.000363	0.000657	CbGpPWpGaD
Lithium—GSK3B—NGF signalling via TRKA from the plasma membrane—IL6—hepatitis B	0.000355	0.000644	CbGpPWpGaD
Lithium—GSK3A—Immune System—HLA-A—hepatitis B	0.000353	0.000639	CbGpPWpGaD
Lithium—GSK3B—Immune System—IFNA2—hepatitis B	0.000348	0.00063	CbGpPWpGaD
Lithium—GSK3B—Immune System—CD14—hepatitis B	0.000348	0.00063	CbGpPWpGaD
Lithium—GSK3A—Innate Immune System—CTNNB1—hepatitis B	0.000347	0.000628	CbGpPWpGaD
Lithium—GSK3A—Innate Immune System—CDKN1A—hepatitis B	0.000339	0.000614	CbGpPWpGaD
Lithium—GSK3A—Innate Immune System—PTEN—hepatitis B	0.000338	0.000612	CbGpPWpGaD
Lithium—GSK3A—Innate Immune System—NFKB1—hepatitis B	0.000336	0.000609	CbGpPWpGaD
Lithium—GSK3A—Disease—CCR5—hepatitis B	0.000334	0.000606	CbGpPWpGaD
Lithium—GSK3B—Disease—GOT1—hepatitis B	0.000331	0.000599	CbGpPWpGaD
Lithium—GSK3A—Disease—HLA-A—hepatitis B	0.000326	0.00059	CbGpPWpGaD
Lithium—GSK3A—Adaptive Immune System—CDKN1A—hepatitis B	0.000325	0.000589	CbGpPWpGaD
Lithium—GSK3A—Adaptive Immune System—PTEN—hepatitis B	0.000324	0.000588	CbGpPWpGaD
Lithium—GSK3A—Adaptive Immune System—NFKB1—hepatitis B	0.000323	0.000585	CbGpPWpGaD
Lithium—GSK3A—Immune System—TLR4—hepatitis B	0.000323	0.000585	CbGpPWpGaD
Lithium—GSK3A—Immune System—HLA-DRB1—hepatitis B	0.000322	0.000584	CbGpPWpGaD
Lithium—GSK3B—Cellular responses to stress—TP53—hepatitis B	0.000318	0.000577	CbGpPWpGaD
Lithium—GSK3A—Metabolism of proteins—CTNNB1—hepatitis B	0.000303	0.000549	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—CXCL10—hepatitis B	0.000302	0.000547	CbGpPWpGaD
Lithium—GSK3B—Immune System—IL18—hepatitis B	0.000297	0.000538	CbGpPWpGaD
Lithium—GSK3B—Immune System—CD40LG—hepatitis B	0.000296	0.000536	CbGpPWpGaD
Lithium—GSK3B—Immune System—CD8A—hepatitis B	0.000292	0.00053	CbGpPWpGaD
Lithium—GSK3B—Cellular responses to stress—IL6—hepatitis B	0.000292	0.000528	CbGpPWpGaD
Lithium—GSK3B—Developmental Biology—CTNNB1—hepatitis B	0.00029	0.000526	CbGpPWpGaD
Lithium—GSK3B—Innate Immune System—CD4—hepatitis B	0.000288	0.000523	CbGpPWpGaD
Lithium—GSK3A—Disease—NOS2—hepatitis B	0.000283	0.000513	CbGpPWpGaD
Lithium—GSK3B—Developmental Biology—NFKB1—hepatitis B	0.000281	0.00051	CbGpPWpGaD
Lithium—GSK3B—Adaptive Immune System—CD4—hepatitis B	0.000277	0.000502	CbGpPWpGaD
Lithium—GSK3B—Signaling by NGF—IL6—hepatitis B	0.000273	0.000496	CbGpPWpGaD
Lithium—GSK3B—Immune System—HLA-A—hepatitis B	0.000261	0.000472	CbGpPWpGaD
Lithium—GSK3B—Innate Immune System—CTNNB1—hepatitis B	0.000256	0.000464	CbGpPWpGaD
Lithium—GSK3B—Innate Immune System—CDKN1A—hepatitis B	0.00025	0.000453	CbGpPWpGaD
Lithium—GSK3B—Innate Immune System—PTEN—hepatitis B	0.00025	0.000452	CbGpPWpGaD
Lithium—GSK3B—Innate Immune System—NFKB1—hepatitis B	0.000248	0.00045	CbGpPWpGaD
Lithium—GSK3B—Axon guidance—IL6—hepatitis B	0.000247	0.000448	CbGpPWpGaD
Lithium—GSK3B—Disease—CCR5—hepatitis B	0.000247	0.000448	CbGpPWpGaD
Lithium—GSK3B—Disease—HLA-A—hepatitis B	0.000241	0.000436	CbGpPWpGaD
Lithium—GSK3B—Adaptive Immune System—CDKN1A—hepatitis B	0.00024	0.000435	CbGpPWpGaD
Lithium—GSK3B—Adaptive Immune System—PTEN—hepatitis B	0.00024	0.000434	CbGpPWpGaD
Lithium—GSK3B—Adaptive Immune System—NFKB1—hepatitis B	0.000239	0.000432	CbGpPWpGaD
Lithium—GSK3B—Immune System—TLR4—hepatitis B	0.000238	0.000432	CbGpPWpGaD
Lithium—GSK3B—Immune System—HLA-DRB1—hepatitis B	0.000238	0.000432	CbGpPWpGaD
Lithium—GSK3A—Immune System—IFNG—hepatitis B	0.000235	0.000427	CbGpPWpGaD
Lithium—GSK3B—Developmental Biology—TGFB1—hepatitis B	0.000234	0.000425	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—CCR5—hepatitis B	0.000234	0.000424	CbGpPWpGaD
Lithium—GSK3A—Immune System—CD4—hepatitis B	0.000227	0.000412	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—CXCL10—hepatitis B	0.000223	0.000404	CbGpPWpGaD
Lithium—GSK3B—Developmental Biology—TNF—hepatitis B	0.000219	0.000397	CbGpPWpGaD
Lithium—GSK3A—Innate Immune System—IL6—hepatitis B	0.000211	0.000382	CbGpPWpGaD
Lithium—GSK3A—Disease—CD4—hepatitis B	0.00021	0.00038	CbGpPWpGaD
Lithium—GSK3B—Disease—NOS2—hepatitis B	0.000209	0.000379	CbGpPWpGaD
Lithium—GSK3A—Immune System—IL2—hepatitis B	0.000209	0.000379	CbGpPWpGaD
Lithium—GSK3A—Immune System—CTNNB1—hepatitis B	0.000202	0.000366	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—F2—hepatitis B	0.000201	0.000364	CbGpPWpGaD
Lithium—GSK3A—Immune System—CDKN1A—hepatitis B	0.000197	0.000357	CbGpPWpGaD
Lithium—GSK3A—Immune System—PTEN—hepatitis B	0.000197	0.000357	CbGpPWpGaD
Lithium—GSK3A—Immune System—NFKB1—hepatitis B	0.000196	0.000355	CbGpPWpGaD
Lithium—GSK3A—Disease—CTNNB1—hepatitis B	0.000186	0.000338	CbGpPWpGaD
Lithium—GSK3A—Disease—CDKN1A—hepatitis B	0.000182	0.00033	CbGpPWpGaD
Lithium—GSK3A—Disease—PTEN—hepatitis B	0.000182	0.000329	CbGpPWpGaD
Lithium—GSK3B—Developmental Biology—IL6—hepatitis B	0.000177	0.00032	CbGpPWpGaD
Lithium—GSK3B—Immune System—IFNG—hepatitis B	0.000174	0.000315	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—CCR5—hepatitis B	0.000173	0.000313	CbGpPWpGaD
Lithium—GSK3B—Immune System—CD4—hepatitis B	0.000168	0.000304	CbGpPWpGaD
Lithium—GSK3B—Innate Immune System—IL6—hepatitis B	0.000156	0.000283	CbGpPWpGaD
Lithium—GSK3B—Disease—CD4—hepatitis B	0.000155	0.000281	CbGpPWpGaD
Lithium—GSK3B—Immune System—IL2—hepatitis B	0.000155	0.00028	CbGpPWpGaD
Lithium—GSK3A—Disease—TGFB1—hepatitis B	0.000151	0.000273	CbGpPWpGaD
Lithium—GSK3B—Immune System—CTNNB1—hepatitis B	0.000149	0.00027	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—F2—hepatitis B	0.000148	0.000269	CbGpPWpGaD
Lithium—GSK3B—Immune System—CDKN1A—hepatitis B	0.000146	0.000264	CbGpPWpGaD
Lithium—GSK3B—Immune System—PTEN—hepatitis B	0.000145	0.000264	CbGpPWpGaD
Lithium—GSK3B—Immune System—NFKB1—hepatitis B	0.000145	0.000262	CbGpPWpGaD
Lithium—GSK3B—Disease—CTNNB1—hepatitis B	0.000138	0.00025	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—IL2—hepatitis B	0.000135	0.000245	CbGpPWpGaD
Lithium—GSK3B—Disease—CDKN1A—hepatitis B	0.000135	0.000244	CbGpPWpGaD
Lithium—GSK3B—Disease—PTEN—hepatitis B	0.000134	0.000243	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—CTNNB1—hepatitis B	0.000131	0.000237	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—CDKN1A—hepatitis B	0.000128	0.000231	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—PTEN—hepatitis B	0.000127	0.000231	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—NFKB1—hepatitis B	0.000127	0.000229	CbGpPWpGaD
Lithium—GSK3A—Immune System—IL6—hepatitis B	0.000123	0.000223	CbGpPWpGaD
Lithium—GSK3A—Disease—IL6—hepatitis B	0.000113	0.000206	CbGpPWpGaD
Lithium—GSK3B—Disease—TGFB1—hepatitis B	0.000111	0.000202	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—TGFB1—hepatitis B	0.000105	0.000191	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—IL2—hepatitis B	9.99e-05	0.000181	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—CTNNB1—hepatitis B	9.65e-05	0.000175	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—CDKN1A—hepatitis B	9.42e-05	0.000171	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—PTEN—hepatitis B	9.4e-05	0.00017	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—NFKB1—hepatitis B	9.36e-05	0.00017	CbGpPWpGaD
Lithium—GSK3B—Immune System—IL6—hepatitis B	9.08e-05	0.000165	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—TP53—hepatitis B	8.68e-05	0.000157	CbGpPWpGaD
Lithium—GSK3B—Disease—IL6—hepatitis B	8.39e-05	0.000152	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—IL6—hepatitis B	7.95e-05	0.000144	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—TGFB1—hepatitis B	7.79e-05	0.000141	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—TP53—hepatitis B	6.42e-05	0.000116	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—IL6—hepatitis B	5.87e-05	0.000106	CbGpPWpGaD
